Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for BioForce Nanosciences Holdings Inc. (BFNH : OTC)
 
 • Company Description   
BioForce Nanosciences Holdings, Inc. develops and commercializes nanotech tools and solutions for the life sciences. BioForce's flagship product, the Nano eNabler molecular printer, gives the Company a platform for development and discovery. BioForce technology is being used in sensor functionalization; patterning and cell adhesion; and printing proteins to guide neural cell growth.

Number of Employees: 2

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.45 Daily Weekly Monthly
20 Day Moving Average: 176 shares
Shares Outstanding: 15.27 (millions)
Market Capitalization: $22.14 (millions)
Beta: -1.44
52 Week High: $1.90
52 Week Low: $0.36
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% 12.62%
12 Week 62.92% 79.10%
Year To Date 20.83% 32.37%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2020 GENERAL BOOTH BLVD UNIT 230
-
VIRGINIA BEACH,VA 23454
USA
ph: 757-306-6090
fax: 757-306-6092
info@bioforcenano.com http://www.bioforceeclipse.com
 
 • General Corporate Information   
Officers
Merle Ferguson - Chief Executive Officer and Chairman
Sasha Shapiro - President
Richard Kaiser - Chief Financial Officer and Secretary
Steve Gagnon - Co Chief Executive Officer
John LaViolette - Co Chief Executive Officer

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 09064C206
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 15.27
Most Recent Split Date: 2.00 (0.20:1)
Beta: -1.44
Market Capitalization: $22.14 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -2,537.62
12/31/21 - -2,050.45
09/30/21 - -1,593.58
Current Ratio
03/31/22 - 0.01
12/31/21 - 0.01
09/30/21 - 0.04
Quick Ratio
03/31/22 - 0.01
12/31/21 - 0.01
09/30/21 - 0.04
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -0.07
12/31/21 - -0.06
09/30/21 - -0.05
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©